American Association for Cancer Research shared a post on LinkedIn:
“The 2024 San Antonio Breast Cancer Symposium showcased breakthroughs like SERDs, PROTACs, and LYTACs, which are revolutionizing breast cancer care. These therapies address resistance and target previously untreatable cancer pathways, signaling a new era in precision oncology.
Learn more on the AACR Blog.”
More posts featuring AACR.